Bioprocesses, which involve biocatalysts for the production of useful compounds, are expected to become a leading player in green chemistry. The first step in bioprocess development is screening for useful biological reactions in the immense number of microorganisms with infinite diversity and versatility. This review introduces some examples of bioprocess development that started from process design stemming from the discovery of unique metabolic processes, reactions, and enzymes in microbial nucleic acid and lipid metabolisms.
In the coming post-petrochemical period, industrial production processes will be required to save energy and to reduce environmental damage. In this sense, biological reactions are now widely recognized as practical alternatives to conventional chemical reactions. 1, 2) On the other hand, novel catalytic procedures are necessary to produce the emerging classes of organic compounds that are becoming the targets of molecular and biomedical research. Therefore, screening for novel biocatalysts that are capable of catalyzing new reactions is constantly needed.
A bioprocess is sometimes designed from the standpoint of organic chemistry, regardless of whether a suitable biocatalyst has been found or not. This forces screening from a certain level to ascertain the existence of a desirable biocatalyst. Thus it is also important to increase the catalog of biocatalysts to maintain the motivation for such a steady search. One of the most efficient and successful means of finding new biocatalysts is to screen large numbers of microorganisms, due to their characteristic diversity and versatility. [3] [4] [5] [6] Information obtained on detailed analysis of a microbial metabolic process leads to new unexpected reactions and substrates. In this review, examples of unique reactions found in the microbial metabolism of nucleic acidrelated compounds and lipid-related compounds are described together with their industrial applications.
I. Analysis and Application of Microbial Nucleic Acid Metabolism

Overview of microbial nucleoside metabolism
Recently, nucleosides and a variety of chemically synthesized nucleoside analogs have attracted a great deal of interest since they have antibiotic, anti-viral, and anti-tumor effects. 7) As part of this trend, the microbial metabolism of nucleosides has been intensively investigated. [8] [9] [10] [11] [12] The first reaction in nucleoside metabolism is N-riboside cleavage. Two kinds of enzymes, nucleosidase (nucleoside hydrolase; EC 3.2.2.-) and nucleoside phosphorylase (EC 2.4.2.-), are known to catalyze this reaction (Fig. 1a) . Nucleosidase catalyzes the irreversible hydrolysis of nucleosides and participates mainly in the assimilation pathway. A nucleosidase from Ochrobactrum anthropi, which specifically catalyzes the N-riboside cleavage of purine nucleosides, has been purified and characterized. 9) The enzyme was found to be useful for the decomposition of purine nucleosides in foodstuffs, the nucleosides causing hyperuricemia, an increasingly common disease in adults. 13) On the other hand, nucleoside phosphorylase catalyzes the phosphorolytic cleavage of nucleosides and shows ribosyl transferase activity. 14) This enzyme functions mainly in the salvage pathway. Nucleoside phosphorylase and the enzymes involved in successive nucleoside degradation were applied to the synthesis of 2 0 -deoxyribonucleoside, as described below.
Biochemical retrosynthesis of 2
0 -deoxyribonucleoside through microbial nucleoside metabolism
With the spread of PCR techniques and new antiviral nucleosides, and the advent of antisense drugs for cancer therapy, there will be an urgent need for a DNA building block, 2 0 -deoxyribonucleoside, on a large scale in the near future. Classical 2 0 -deoxyribonucleoside sources are hydrolyzed herring and salmon sperm DNA. These y To whom correspondence should be addressed. Tel: +81-75-753-6122; Fax: +81-75-753-6128; E-mail: ogawa@kais.kyoto-u.ac.jp * Present address: Novozymes Japan, Mihama-ku, Chiba 261-8501, Japan ** Present address: Department of Medicinal Chemistry, University of Kansas, Lawrence, KS 66045-7582, USA sources, however, will not allow us to meet future demands for a stable and economical supply of 2 0 -deoxyribonucleoside. A possible microbial method for 2 0 -deoxyribonucleoside production from easily available materials, glucose, acetaldehyde, and a nucleobase, has been examined-that is, the use of reversible reactions involved in nucleoside degradation. The enzymes involved in the process are: (i) glycolytic enzymes, which generate D-glyceraldehyde 3-phosphate from glucose, (ii) deoxyriboaldolase, which catalyzes the condensation of acetaldehyde and D-glyceraldehyde 3-phosphate to yield 2-deoxyribose 5-phosphate, (iii) phosphopentomutase, which catalyzes the intermolecular transfer of phosphate from 2-deoxyribose 5-phosphate to 2-deoxyribose 1-phosphate, and (iv) nucleoside phosphorylase, which catalyzes nucleobase transfer to the pentosyl moiety to generate 2 0 -deoxyribonucleosides (Fig. 2) . A deoxyriboaldolase suitable for 2-deoxyribose 5-phosphate synthesis with tolerance to acetaldehyde was found in Klebsiella pnuemoniae, 10) and the gene was transformed into Escherichia coli.
11) The metabolic flow of deoxyriboaldolase-expressing E. coli has been examined, and it was found that glucose was transformed to 2-deoxyribose 5-phosphate by the E. coli in the presence of a suitable energy source such as ATP.
11) Furthermore, phosphorylated glycolysis intermediates such as fructose 1,6-diphosphate were found to be potential substrates for 2-deoxyribose 5-phosphate production by deoxyriboaldolase-expressing E. coli cells. 11) Coupling with the glycolytic pathway of baker's yeast, an energy and phosphorylated intermediate-generating system, was effective.
12) The glycolytic pathway of baker's yeast gave fructose 1,6-diphosphate from glucose, driven by the energy of ATP generated from AMP or adenosine by alcoholic fermentation of the yeast, and fructose 1,6-diphosphate was further transformed to 2-deoxyribose 5-phosphate by deoxyriboaldolase-expressing E. coli via D-glyceraldehyde 3-phosphate. E. coli transformants expressing phosphopentomutase, and nucleoside phosphorylase produced 2 0 -deoxyribonucleoside from 2-deoxyribose 5-phosphate and a nucleobase via 2-deoxyriobse 1-phosphate.
12) It is noteworthy that coupling of the glycolytic pathway with deoxyriboaldolase efficiently supplies 2-deoxyribose 5-phosphate (approximately 250 mM). The amount of 2 0 -deoxyribonucleside reached about 60 mM. This is the first report of 2 0 -deoxyribonucleoside production from such inexpensive materials as glucose, acetaldehyde, and a nucleobase. 
Overview of microbial nucleobase-related compound metabolisms
The metabolism of nucleobases such as pyrimidines and purines involves various cyclic amide hydrolases (EC 3.5.2.-), such as dihydropyrimidinase in reductive pyrimidine metabolism 15) (Fig. 1c) , barbiturase in oxidative pyrimidine metabolism 16) (Fig. 1b) , dihydroorotase in pyrimidine biosynthesis, 17) and allantoinase in purine metabolism (Fig. 1g) . 18) In the 1970s, studies on rat liver dihydropyrimidinase in reductive pyrimidine metabolism showed that the enzyme hydrolyzed 5-monosubstituted hydantoin to N-carbamoyl amino acid, and that the reaction proceeded D-stereospecifically. 19, 20) Later on, Yamada and co-workers showed that microbial cells are good catalysts for this reaction. 21) Based on these results, hydantoin metabolism in microorganisms was intensively studied and applied to optically active amino acid production. 22, 23) Blastobacter sp. A17p-4 was screened from soil as a hydantoin-assimilating bacterium for the purpose of D-amino acid production from DL-5-monosubstituted hydantoins. 24) During the course of studies on hydantoin metabolism in this bacterium (Fig. 1d) , it was found that it showed not only hydantoin-but also cyclic imide-metabolizing activity. 25) A recent study revealed that the strain has not only hydantoin-metabolizing enzymes but also enzymes specific to cyclic imide derivatives, as described below (Fig. 1e) .
While the reductive pyrimidine metabolism attracted much attention, the oxidative pyrimidine metabolism was not studied in detail. The enzymes in the oxidative pathway were investigated in Rhodococcus erythropolis JCM 3132, and the involvement of uracil/thymine dehydrogenase, barbiturase, and ureidomalonase was revealed (Fig. 1b) . 26) Uracil/thymine dehydrogenase is a molybdenum-containing iron-sulfur flavoprotein, and transformed uracil to barbiturate with methylene blue as an electron acceptor. The enzyme activity was enhanced by cerium (Ce), a rare-earth metal. Barbiturase, a zinc-containing cyclic amide hydrolase, transformed barbiturate to ureidomalonate, 16) and ureidomalonase successively transformed ureidomalonate to malonate and urea. The oxidative pathway is promising for control of the reaction equilibrium of the nucleoside phosphorylase-catalyzing base-exchange reaction, which is useful for anti-viral nucleoside analog synthesis. 27) 
Analysis and application of microbial hydantoin metabolism
Hydantoin is metabolized to an amino acid through two-step hydrolysis via an N-carbamoyl amino acid (Fig. 1d) . The enzyme catalyzing the first step, hydrolysis of hydantoin to N-carbamoyl amino acid, is called hydantoinase. Three typical hydantoinases with stereospecificity to D-, L-, and DL-5-monosubstituted hydantoin are named D-hydantoinase, L-hydantoinase, and DLhydantoinase. 23, [28] [29] [30] D-Hydantoinases have been found in various genera of bacteria such as Pseudomonas, Bacillus, Blastobacter, and Arthrobacter, and most of them show dihydropyrimidinase activity. L-and DLhydantoinases might be rarer in nature than D-hydantoinase. These enzymes can be divided into two groups: one needing ATP for activity and the other not. The ATP-requiring enzyme from Pseudomonas putida 77, which functions in creatinine metabolism, showed Lhydantoinase activity. 31) The second step in hydantoin metabolism, N-carbamoyl amino acid hydrolysis to amino acid, ammonia, and carbon dioxide, is catalyzed by carbamoylase. Two typical carbamoylases with stereospecificity to N-carbamoyl D-and L-amino acids are named D-carbamoylase and L-carbamoylase. 23 ) D-Carbamoylase generally shows wide substrate specificity to both aromatic and aliphatic N-carbamoyl-D-amino acids.
32) L-Carbamoylase shows rather limited specificity to aromatic or aliphatic Ncarbamoyl-L-amino acids. An L-carbamoylase with relatively broad substrate specificity has been found in Alcaligenes xylosoxidans.
33) -Ureidopropionase from P. putida IFO 12996, which functions in pyrimidine degradation during N-carbamoyl--alanine hydrolysis, showed broad substrate specificity not only toward Ncarbamoyl--amino acids, but also N-carbamoyl--amino acids and several N-carbamoyl--L-amino acids. 34) Different combinations of hydantoin-metabolizing enzymes, viz. hydantoinases and carbamoylases, provide a variety of processes for the production of optically pure -amino acids (Fig. 3) .
23) The broad substrate range of the processes is valuable, especially for the production of D-amino acids and unnatural L-amino acids. [35] [36] [37] A practical representative is the production of D-phydroxyphenylglycine, a building block for semisynthetic penicillins and cephalosporins, from racemic 5-(phydroxyphenyl)hydantoin. The process, involving one chemical step for racemic 5-(p-hydroxyphenyl)hydantoin synthesis from phenol, glyoxylic acid, and urea, and two enzymatic steps with immobilized D-hydantoinase and D-carbamoylase, 38, 39) has been used in commercial production since 1995. In this process, the L-isomer of the remaining 5-(p-hydroxyphenyl)hydantoin is racemized through base catalysis under alkaline conditions. Therefore, racemic hydantoin can be converted quantitatively into D-p-hydroxyphenylglycine through the total process.
Some enzymes involved in hydantoin metabolisms recognize multi-chiral centers other than the -carbons of amino acids, so they make possible simultaneous resolution of multi-chiral amino acids such asmethylphenylalanine. 40) 
Analysis and application of microbial cyclic imide metabolism
Based on the finding of cyclic imide-hydrolyzing activity in Blastobacter sp., 25) the metabolism of various cyclic imides by microorganisms has been investigated. Blastobacter sp. can metabolize various cyclic imides such as succinimide, maleimide, 2-methylsuccinimide, and glutarimide, and sulfur-containing cyclic imides such as 2,4-thiazolidinedione and rhodanine. 41) Further investigation of the metabolic fate of these cyclic imides showed that they were metabolized through a novel metabolic pathway (Fig. 1e) . This pathway comprises in turn the hydrolytic ring-opening of cyclic imides into half-amides, hydrolytic deamidation of the half-amides to dicarboxylates, and dicarboxylate transformation similar to that in the tricarboxylic acid (TCA) cycle.
Cyclic imide metabolism has been applied to the production of a high-value organic acid, pyruvate. 42) Commercial demand for pyruvate has been increasing due to its use as an effective precursor in the synthesis of various drugs and agrochemicals in addition to its use as a component of mammalian-cell culture media. Pseudomonas putida S52 isolated with succinimide as the sole carbon source exhibits highly active cyclic imide metabolism. This activity has been used for pyruvate production from fumarate, an inexpensive cyclic imide metabolism intermediate (Fig. 4a) . Bromopyruvate-resistant mutants derived from P. putida S52 produced 770 mM pyruvate from 1,000 mM fumarate in 96 h.
Two novel enzymes, imidase and half-amidase, and D-hydantoinase were found to function in this pathway. Three types of imidases with different substrate specificities were found. An imidase with specificity toward simple cyclic imides was purified from Blastobacter sp. 43) This enzyme is also active toward sulfur-containing cyclic imides such as 2,4-thiazolidinedione and rhodanine. Bulky cyclic imides are hydro- lyzed by the D-hydantoinase of Blastobacter sp. and mammalian dihydropyrimidinases. 44) Another imidase, phthalimidase, with specificity toward phthalimide derivatives was found in Alcaligenes ureafaciens. 45) Half-amides, the products of imidase, were further metabolized to dicarboxylates by half-imidase. The enzyme was purified from Blastobacter sp. and found to be specific toward half-amides. 46) These enzyme activities are widely distributed among bacteria, yeast, and molds. 47) Based on these findings, potential imidases that are applicable to the regiospecific hydrolysis of 2,3-pyridinedicarboxyimide to 3-carbamoyl--picolinic acid were screened (Fig. 4b) . 3-Carbamoyl--picolinic acid is a promising intermediate for modern insecticide synthesis, but there is a synthetic difficulty in selective amidation at one of two equivalent carboxyl groups. Phthalimide-assimilating Arthrobacter ureafaciens O-86 was selected as the best strain and applied to the cyclohexanone-water two phase reaction system, pH 5.5, in which the spontaneous random hydrolysis of 2,3-pyridinedicarboxyimide was avoided and the enzyme maintained its activity. Under optimized conditions, with the periodical addition of 2,3-pyridinedicarboxyimide (in total, 40 mM), 36.6 mM 3-carbamoyl--picolinic acid accumulated in the water phase with a molar conversion yield of 91.5% and a regioisomeric purity of 94.5% in 2 h. 45) Based on the finding that imidase hydrolyzes sulfurcontaining cyclic imides, enzymatic stereoselective conversion of thiazolidinedione derivatives to optically active -mercapto acids was established in a fashion similar to the hydantoinase process for optically active -amino acid production (Fig. 4c) . As well as -amino acid, -mercapto acid, which contains a chiral center at -carbon, has been gathering increasing attention as a novel chiral building block for the synthesis of pharmaceuticals. Brevibacterium linens C-1 and Pseudomonas sp. Y7 were found to produce S-and R-3-phenyl-2-mercaptopropionic acid respectively from racemic 5-benzyl-2,4-thiazolidinedione. The cyclic imide hydrolase purified from B. linens C-1 showed allantoinase activity, indicating a metabolic relation with purine base metabolism (Fig. 1f, g ).
L-Carbamoylase
II. Analysis and Application of Microbial Lipid Metabolism
Fatty acid metabolism useful for conjugated fatty acid production
Conjugated fatty acids have attracted much attention as a novel type of biologically beneficial functional lipids. For example, dietary conjugated linoleic acid (CLA) reduces carcinogenesis, atherosclerosis, and body fat. 48, 49) Today, CLA is produced through chemical isomerization of linoleic acid, which results in the byproduction of unexpected isomers. Considering the use of CLA for medicinal and nutraceutical purposes, an isomer-selective and safe process is required. A bioprocess is a potential alternative for this purpose.
Dairy products are among the major natural sources of CLA, of which cis-9,trans-11-octadecadienoic acid is the main isomer. 50) CLA has been shown to be produced from polyunsaturated fatty acids by certain rumen microorganisms such as Butyrivibrio species. It has been suggested that cis-9,trans-11-octadecadienoic acid is an intermediate in the biohydrogenation of linoleic acid to octadecaenoic acid by the anaerobic rumen bacterium Butyrivibrio fibrisolvens.
51) It has also been reported that Propionibacterium freudenreichii, which is commonly used as a dairy starter culture, can produce CLA from free linoleic acid. 52) Recently, the ability to produce CLA from linoleic acid was extensively screened for in lactic acid bacteria. 53, 54) Many strains were found to produce CLA from linoleic acid, and the mechanism of CLA production was investigated with Lactobacillus acidophilus AKU 1137 as a representative strain.
55) The CLAs produced by L. acidophilus were identified as cis-9,trans-11-octadecadienoic acid (CLA1) and trans-9,trans-11-octadecadienoic acid (CLA2). 56) Preceding the production of CLA, hydroxy fatty acids identified as 10-hydroxy-cis-12-octadecaenoic acid and 10-hydroxy-trans-12-octadecaenoic acid accumulated. Isolated 10-hydroxy-cis-12-octadecaenoic acid was transformed to CLA on incubation with washed cells of L. acidophilus, suggesting that this hydroxy fatty acid is one of the intermediates of CLA production from linoleic acid (Fig. 5a ). L. plantarum AKU 1009a was selected as a potential strain for CLA production from linoleic acid.
53) The washed cells of L. plantarum produced 40 mg/ml CLA (33% molar yield) from 12% (w/v) linoleic acid in 108 h. The resulting CLA, mainly as a free fatty acid form, comprised a mixture of CLA1 (38% of total CLA) and CLA2 (62% of total CLA), and accounted for 50% of the total fatty acids obtained. In a similar manner, on linoleic acid transformation to CLA, lactic acid bacteria transformed -and -linolenic acid into the corresponding conjugated trienoic acids. 54, 57) Those produced from -linolenic acid were identified as cis-9,trans-11,cis-15-octadecatrienoic acid and trans-9,trans-11,cis-15-octadecatrienoic acid, and those from -linolenic acid as cis-6,cis-9,trans-11-octadecatrienoic acid and cis-6,trans-9,trans-11-octadecatrienoic acid (Fig. 5b) .
Based on the finding of hydroxyl fatty acids as intermediates in CLA production, the transformation of hydroxy fatty acids by lactic acid bacteria was investigated. Lactic acid bacteria transformed ricinoleic acid (12-hydroxy-cis-9-octadecaenoic acid) into CLA (a mixture of CLA1 and CLA2). 58) There are two possible pathways for CLA synthesis from ricinoleic acid by lactic acid bacteria: (i) direct transformation of ricinoleic acid into CLA through dehydration at the Á11 position, and (ii) dehydration of ricinoleic acid at the Á12 position to linoleic acid, which is a potential substrate for CLA production by lactic acid bacteria (Fig. 5a ). L. plantarum JCM 1551 was selected as a potential catalyst for CLA production from ricinoleic acid. 59) With the free acid form of ricinoleic acid as the substrate and washed cells of L. plantarum as the catalyst, 2.4 mg/ml CLA was produced from 3.4 mg/ml ricinoleic acid in 90 h, the molar yield as to ricinoleic acid being 71%. The CLA produced, mainly in a free fatty acid form, consisted of CLA1 (21% of total CLA) and CLA2 (79% of total CLA), and it accounted for 72% of the total fatty acids obtained. 59) Ricinoleic acid is abundant in a plant oil, castor oil. Castor oil is an economical source of ricinoleic acid. In the presence of lipase, castor oil became an effective substrate for CLA production by lactic acid bacteria.
60) The addition of a polyhydroxy-type detergent enhanced CLA production from castor oil.
Certain molds have been found to produce CLA from trans-vaccenic acid (trans-11-octadecenoic acid) through Á9-desaturation (Fig. 5c) . 54) Delacroixia coronata IFO 8586 produced about 10 mg/ml CLA, mainly as triacylglycerol from free trans-vaccenic acid during cultivation. CLA1 was produced with about 98% isomer selectivity.
Protein engineering of a fatty acid monooxygenase
Cytochrome P450 BM-3 from Bacillus megaterium is a fatty acid monooxygenase. Its substrate specificity was expanded to aromatic hydrocarbons and phenolic and arylalkyl compounds by means of crystal structurebased directed mutation, which resulted in the creation of novel catalysts for regiospecific and stereospecific alcohol synthesis. [61] [62] [63] [64] [65] [66] The activity of a triplet mutant (A74G/F87V/L188Q) towards polycyclic aromatic hydrocarbons such as naphthalene, fluorene, acenaphthene, acenephthylene, and 9-methylanthracene was improved by up to four orders of magnitude compared to that of the wild-type enzyme.
62) The same mutant enzyme had 2-12 times higher activity than the wild-type enzyme towards polychlorinated dibenzo-p-dioxins. The products were hydroxylated at an unsubstituted position and/or showed migration of the chloride, and were less toxic derivatives with less than 10% of the toxicity of the original compounds. 64) The single mutant (F87V) showed greatly increased activity towards a variety of aromatic and phenolic compounds. Furthermore, the mutant enzyme catalyzed regioselective hydroxylation at the para position of various phenolic compounds. In particular, the mutant enzyme showed high activity as to the hydroxylation of 2-(benzyloxy)phenol to 2-(benzyloxy)hydroquinone, a pharmaceutical intermediate. 66) 0.71 mg/ml 2-(benzyloxy)hydroquinone was produced from 1 mg/ml 2-(benzyloxy)phenol in 4 h, with a molar yield of 66%.
The wild-type enzyme catalyzed regio-and stereoselective hydroxylation of propylbenzene. The hydroxylation of propylbenzene occurred at a specific position and stoichiometrically produced 1-phenyl-1-propanol with 90% e.e. for the R-isomer.
63) The single mutant (F87V) catalyzed stereoselective epoxidation of 3-chlorostylene with an enantiomeric purity of 94.6% e.e. for the R-isomer.
63)
III. Conclusions: Expansion of Biocatalysts for Practical Purposes
Reactions found through detailed observation of microbial nucleic acid and lipid metabolisms have paved the way to new bioprocesses for the production of 2 0 -deoxyribonucleosides, optically active amino acids, organic acids, half-amides, optically activemercapto acids, conjugated fatty acids, hydroxylated polycyclic aromatic hydrocarbons, hydroquinone derivatives, chiral alcohols, and so on. Modern society requires the development of processes exhibiting environmental harmony and economical efficiency. This trend is causing the application of biological reactions in a greater variety of industries. But the feasibility of new bioprocesses will often be determined by the availability of biocatalysts, the search for which requires patience for steady research but offers a deep reward when a new biocatalyst is encountered.
Recently, rational methods for creating new biocatalysts have been rapidly developed. Modern gene technology, crystal structure analysis, and bio-informatics make possible the modulation of enzyme functions through site-directed mutagenesis, DNA shuffling, and so on. One example is modification of the substrate specificity of a fatty acid monooxygenase, cytochrome P450 BM-3, as described above. But rationality is not the only answer in developing new biocatalysts. Classical screening based on microbial diversity and versatility is still important. Such screening is something like a midnight walk without moonlight, but detailed observation and deep insight with a well-considered strategy will lead to the discovery of new biocatalysts. This philosophy became a basic idea of in vitro random evolution technology. 67) The industrial success of biocatalysts unfortunately depends on the economics of the specific processes, but one success provides enormous opportunities, and with the introduction of each new process accumulating experience and confidence, it becomes easier to develop and justify the next new bioprocess. Thus, it is important for practical purposes to increase the catalog of biocatalysts waiting to be examined.
